Loading…
The DiaTrust Covid-19 IgG/IgM Rapid Test, jointly developed by Celltrion and Humasis, received FDA emergency use authorization. Celltrion USA also signed a $214.5 million supply contract with Prime Healthcare Distributors.
Celltrion USA has signed a $22 million contract to supply its SAMPINUT rapid antigen test kits to the US, following FDA Emergency Use Authorization.